Fibrin Glue Reduces the Duration of Lymphatic Drainage after Lumpectomy and Level II or III Axillary Lymph Node Dissection for Breast Cancer: A Prospective Randomized Trial by Ko, Eunyoung et al.
INTRODUCTION
Prolonged lymphatic drainage following axillary dissection
in breast cancer remains a significant clinical problem Short-
ening the drainage duration is associated with shorter in-pa-
tient times and hence lower health care costs. Methods applied
to reduce lymphatic drainage include compression dressings
(1), closed suction drains (2), postoperative shoulder immo-
bilization (3) and fibrin glue application to the axillary dis-
section site (4-6).
The use of fibrin glue may reduce lymphatic drainage by
reducing the number of transections of small vessels and lym-
phatics during axillary lymph node removal (7). However, con-
flicting clinical trial results exist regarding fibrin glue use in
breast cancer surgery. Previous trials involved a wide variety
of breast cancer surgery types or degrees of axillary dissection
(8).
The present randomized study investigated the effect of fib-
rin glue use on the duration of drainage and overall drain out-
put after breast lumpectomy and axillary dissection for breast
cancer.
MATERIALS AND METHODS
Participants
A prospective, randomized study was performed between
September 2006 and July 2007 at the Department of Surgery,
Seoul National University Hospital. The inclusion criteria
(9) were 1) newly diagnosed breast cancer, 2) female gender,
3) elective breast lumpectomy and axillary dissection, 4)
informed consent, and 5) being outside of any exclusion cri-
teria. The exclusion criteria (9) were: 1) male gender, 2) a
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Fibrin Glue Reduces the Duration of Lymphatic Drainage after
Lumpectomy and Level Ⅱ or Ⅲ Axillary Lymph Node Dissection for
Breast Cancer: A Prospective Randomized Trial
This randomized prospective study investigated the effect of fibrin glue use on dr-
ainage duration and overall drain output after lumpectomy and axillary dissection in
breast cancer patients. A total of 100 patients undergoing breast lumpectomy and
axillary dissection were randomized to a fibrin glue group (N=50; glue sprayed onto
the axillary dissection site) or a control group (N=50). Outcome measures were
drainage duration, overall drain output, and incidence of seroma. Overall, the fibrin
glue and control groups were similar in terms of drainage duration, overall drain
output, and incidence of seroma. However, subgroup analysis showed that fibrin
glue use resulted in a shorter drainage duration (3.5 vs. 4.7 days; p=0.0006) and
overall drain output (196 vs. 278 mL; p=0.0255) in patients undergoing level II or III
axillary dissection. Fibrin glue use reduced drainage duration and overall drain out-
put in breast cancer patients undergoing a lumpectomy and level II or III axillary dis-
section.
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body mass index (kg/m2) <18.5 or >30, 3) current steroid
use, 4) systemic anticoagulation or significant coagulation
disorder, 5) diabetes, 6) heart disease, 7) history of chest
radiation, 8) receiving preoperative chemotherapy, 9) planned
immediate breast reconstruction, 10) pregnant or lactating,
11) limited to sentinel node biopsy, or 12) no consent. The
study was approved by the Institutional Review Board of the
Seoul National University Hospital.
Treatment protocol
Surgery was performed by two surgeons using principally
identical methods. All patients underwent a lumpectomy and
level I or greater axillary lymph node dissection, and an effort
was made to ligate major vessels. For the patients in the fibrin
glue group, fibrin glue (Greenplast kit
�, Green Cross, Seoul,
Korea) was mixed intraoperatively and diluted twice accord-
ing to standard instructions, and 2 mL was sprayed onto the
axillary dissection site using an aerosol spray applicator (Green
Jet V2
�, Green Cross, Seoul, Korea), after which manual com-
pression was applied for 2 min according to manufacturer’s
manual. A Jackson-Pratt closed suction 100 mL/3.2 mm drain
was placed into the axillary dissection site for all patients.
Compression dressings with surgical bras and pads were ap-
plied to all patients for the first 5 days after surgery. Arm
movement was restricted to below 90 degrees for 5 days (3).
Participants were discharged on postoperative day 5±1
regardless of drain removal, and were routinely followed-up
on postoperative days 12±1 and 30±2.
Outcomes
The primary outcome measure was the duration of drainage.
Drainage was assessed daily from the day of surgery, and drains
were removed when the drainage volume fell to <30 mL over
a 24-hr period. Secondary outcome measures were overall drain
output and the incidence of symptomatic seroma formation.
A symptomatic seroma was defined as a palpable fluid col-
lection under the wound with symptoms, and was treated
using aspiration or open drain insertion. In addition, all wo-
und-related complications were recorded. The wound was
examined daily until discharge and during each clinic visit.
Wound infections were defined as erythema and/or purulent
discharge from the incision site, and were treated using an
oral antibiotic for at least 3 days.
Sample size
The primary endpoint was the duration of drainage. In a
pilot study with 21 patients, the mean drainage duration was
3.0 days for the case group and 3.2 days for the control group,
and the standard deviation of the mean difference between
the case and control groups was 0.255. The current study had
a power of 90 percent to show whether the drainage duration
differed between the fibrin glue and non-fibrin glue groups.
This approach assumed that the drainage duration for the two
groups was equal, and that a difference of 10 percent or less
was clinically irrelevant.
This approach required each group to have a sample size
of 49 considering a 30% dropout, and α(two-sided) was set
at 0.05. The enrollment procedure engaged 50 patients per
group.
Randomization
Patients were randomized using a web-based program host-
ed at the Medical Research Collaborating Center at Seoul Na-
tional University Hospital. Participant randomization was
done after bleeding control and confirmation of a negative
margin status, immediately before wound closure. Fig. 1 shows
the Consolidated Standards of Reporting Trials (CON-
SORT) flow chart outlining the progress of participants
through the study (10). One hundred participants were ran-
domized, 50 to the fibrin glue group and 50 to the control
group (non-fibrin glue). Three fibrin glue patients and two
control patients were excluded after randomization due to
postoperative bleeding.
Blinding
The surgical team was ‘blinded’ to treatment assignment
until the completion of the surgical dissection and bleeding
control just prior to randomization. The personnel involved
in recording drainage volumes and complications were also
blinded to the treatment assignment. 
No agent
(Control group)
(n=50)
Fibrin glue
(Case group)
(n=50)
Follow up
to the end point
(n=48)*
Follow up
to the end point
(n=47)*
Primary breast cancer
Breast conserving surgery
with axillary dissection Ineligible for trial
BMI<18.5 kg/m
2 or ≥30 kg/m
2
History of diabetes or heart disease
History of chest irradiation
Receiving preoperative chemotherapy
On systemic anticoagulation
Ongoing systemic infection
Planned breast reconstruction
Pregnant or lactating patient
Limited to sentinel lymph node biopsy
No informed consent
Randomized in the study
(n=100)
Fig. 1. Study flow chart.
BMI, body mass index; body weight (kg)/height
2 (m
2).
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Statistical methods
Data were stored using the Excel (Microsoft Corporation,
Redmond, WA, U.S.A.) spread sheet program, and statisti-
cal analyses were performed using SPSS software version 12.0
(SPSS, Chicago, IL, U.S.A.) and SAS (SAS Inc., Cray, NC,
U.S.A.). Outcome criteria were analyzed on an intension-to-
treat basis and all tests were two-tailed. Qualitative data were
compared using the Pearson’s chi-square-test for more than
30 samples and Fisher’s exact test for less than 30 samples.
Quantitative data were expressed as means (standard devia-
tions), and were compared using Student t-tests for all group
samples and using Mann-Whitney U tests for subgroup
samples. Using the general linear model (GLM) procedure,
two-way analysis of variance (ANOVA) was used to identify
subgroups showing the greatest benefit from use of fibrin
glue. A pvalue <0.05 was considered to indicate a significant
difference.
RESULTS
Of the 100 patients enrolled (50 fibrin glue, 50 control),
95 completed the study to the endpoint. All five of those that
did not complete the study developed postoperative bleeding
on the day of surgery, and four of them were conservatively
treated (compression dressing with elastic bandage and open
drain insertion) and the other underwent re-exploration for
bleeding control and hematoma evacuation. It was not pos-
sible to measure the drainage duration or overall drain out-
put in those five patients because the Jackson-Pratt closed
suction drain was removed and an open drain inserted.
There were no significant differences between the fibrin glue
and control groups with respect to age, body mass index
(BMI), tumor size, the number of lymph nodes removed,
and the number of tumor- involved lymph nodes (Table 1).
Level I axillary dissection and node-negative status were found
to be associated with a shorter drainage duration (p=0.0001
and p=0.004, respectively) and lower overall drain output (p=
0.0001 and p=0.003, respectively), while other factors such as
age <60 yr and BMI <25 kg/m2 were not (Table 2).
Duration of drainage, overall drain output and
complications
The mean drainage duration was 3.3 days for the fibrin
glue group and 3.8 days for the control group (p=0.067). The
overall drain output was 174 mL for the fibrin glue group and
197 mL for the control group (p=0.309). The differences be-
tween groups for these two factors were not found to be sta-
tistically significant (Table 2). In addition, the fibrin glue and
control groups were found to be similar in terms of the inci-
dence of seroma, postoperative bleeding and wound infection
(Table 4). 
Subgroup analysis
Participants were classified according to two categorical
factors and the data underwent an analysis of variance. One
factor was the use of fibrin glue and the other factor was the
axillary dissection level or node status. The variance between
groups classified according to the use of fibrin glue and axil-
lary dissection level was significant in terms of drainage dura-
tion (p=0.0005) and overall drain output (p=0.0098) (Table
3). The drainage duration was shorter (3.5 vs. 4.7 days; p=
0.0006) and the overall drain output was lower (196 vs. 278
mL; p=0.0255) in the fibrin glue group compared with the
control group among those undergoing level II or III axillary
*Values represent mean±standard deviation. Significance was tested
using 
� Student’s t-tests and 
� Pearson chi-square tests.
BMI, body mass index.  
Variables Fibrin glue group Control group p
No. of participants 47 48
Age (yr)* 48.5±8.7 47.9±7.7 0.784
�
BMI (kg/m
2)* 23.7±2.9 23.0±2.2 0.188
�
Tumor size (cm)* 2.1±0.9 1.8±0.8 0.097
�
No. removed nodes* 12.6±5.6 12.5±6.0 0.813
�
No. of tumor-involved nodes* 0.8±1.8 0. 8±1.3 0.895
�
Highest level of axillary dissection 0.995
�
Level I 25 26
Level II 15 15
Level III 7 7
Table 1. Patient characteristics
Significance was determined using Student’s t-tests.
BMI, body mass index.
Duration of  Overall drain 
Variables
drainage
p
output
p
Mean±SD Mean±SD
(day) (mL)
Use of fibrin glue 0.067 0.309
No (n=47) 3.8±1.4 197±132
Yes (n=48) 3.3±0.9 174±87
Highest axillary level 0.0001 0.0001
Level I (n=51) 3.1±0.9 142±80
Level II or III (n=44) 4.1±1.3 237±123
Node status 0.004 0.003
Node negative (n=59) 3.3±1.0 157±86
Node positive (n=36) 4.0±1.3 234±133
BMI (kg/m
2) 0.533 0.364
19.5-24 (n=67) 3.5±1.1 179±93
25-30 (n=28)  3.7±1.4 202±150
Age 0.888 0.408
<60 yr (n=85) 3.6±1.2 189±114
≥60 yr (n=10) 3.5±1.1 160±102
Table 2. Univariate analysis of the association between clinico-
pathological variables and drainage duration or overall drain
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dissection. These differences were not apparent in those under-
going level I axillary dissection. While the data appeared to
suggest there may have been a greater benefit from the use
of fibrin glue in patients with a positive node status compared
with a negative node status, the differences were not statis-
tically significant (p=0.0818 for drainage duration and p=
0.1123 for overall drain output).
DISCUSSION
While prolonged axillary lymphatic drainage is not a seri-
ous complication after axillary dissection in breast cancer, it
remains the main cause of prolonged hospital stays resulting
in increased health care costs. Therefore, several approaches
have been used to reduce axillary lymphatic drainage, such
as the use of fibrin glue and immobilization of the affected
arm (11). 
Although Lindsey et al. (12) reported that fibrin glue re-
duced lymphatic drainage in rats, conflicting results have been
reported in clinical trials. Five studies (4-6, 9, 13) have exam-
ined the association between fibrin glue use and drainage dura-
tion or overall drain output. Three of those studies (4-6) show-
ed that fibrin glue reduced both axillary lymphatic drainage
and drainage duration, while two (9, 13) reported that fib-
rin glue had no effect on either axillary lymphatic drainage
and drainage duration. Moreover, a meta-analysis of several
published trials (8) reported that while the data appeared to
suggest decreased overall drain output and a shorter drainage
duration in patients receiving fibrin sealant, the findings were
not statistically significant. Those studies enrolled almost ex-
clusively mastectomy cases or various cases rarely involving
lumpectomy, therefore making it difficult to accurately eval-
uate axillary lymphatic drainage due to the influence of fluid
from the mastectomy site or the heterogeneity of surgery. 
The present study enrolled patients undergoing only breast
lumpectomy and axillary dissection to minimize the influ-
ence of fluid from mastectomy or lumpectomy. The analysis
of all patients showed that fibrin glue use did not reduce the
drainage duration or the overall drain output. However, sub-
group analysis showed that the use of fibrin glue reduced both
drainage duration and overall drain output in patients under-
going level II or III axillary dissection. Fibrin glue had no such
effect in patients undergoing level I axillary dissection.
The current study found that in both fibrin glue and con-
trol groups, drainage duration and overall drain output in-
creased as the level of axillary dissection or nodal stage inc-
reased, and that the benefit from the use of fibrin glue was
greater in those undergoing higher level dissections. More-
over, the data suggest that a study using a larger population
may find that there is greater benefit from fibrin glue use in
node-positive patients compared to node-negative patients.
The present results suggest that fibrin glue use will be ben-
eficial under conditions of high drainage, such as axillary dis-
section extended to two or three levels, higher nodal stage (14),
following preoperative chemotherapy, old age (2) and obesi-
ty (11). In contrast to previous studies (2, 11), the present
study did not find an association between lymphatic drainage
Significance was tested using *two-way analysis of variance between groups or 
� Mann-Whitney U-tests.
Fibrin glue group Control group
p
No. Mean±SD No. Mean±SD
Duration of drainage (days)
Highest axillary dissection level 0.0005*
Level I 25 3.2±1.0 26 3.0±0.8 0.3444
�
Level II or III 22 3.5±0.9 22 4.7±1.4 0.0006
�
Nodal status 0.0818*
Node negative 30 3.2±0.9 29 3.3±1.2 0.6884
�
Node positive 17 3.5±0.9 19 4.5±1.5 0.0271
�
Overall drain output (mL)
Highest axillary dissection level 0.0098*
Level I 25 154±90 26 129±67 0.2607
�
Level II or III 22 196±80 22 278±146 0.0255
�
Nodal status 0.1123*
Node negative 30 160±88 29 154±86 0.7851
�
Node positive 17 199±82 19 265±162 0.1432
�
Table 3. Subgroup analysis of the effect of fibrin glue on drainage duration and overall output
Significance was tested using Pearson chi-square tests.
Event
Fibrin glue group Control group
p
(n=50) (n=50)
Seroma 10 ( 12 ( 0.667
Postoperative bleeding 3 ( 2 ( 0.630
Wound infection 3 ( 2 ( 0.630
Total (%) 16 (32%) 16 (32%)
Table 4. Complications96 E. Ko, W. Han, J. Cho, et al.
and age or obesity. This may have been because in this study
the body mass index of participants was restricted ≤30 kg/m2
and the number of participants aged ≥60 yr was only 10. 
The current study found that the use of fibrin glue did not
prevent seroma formation, which is consistent with other re-
ports (4, 6, 8, 9, 13). One explanation is that perhaps fibrin
glue had only a short and transient effect on drainage (4). De-
spite subgroup analysis showing a shorter drainage duration
in the fibrin glue group compared to the control group, the
groups did not differ in terms of seroma formation or the num-
ber of outpatient clinic visits due to wound issues. Thus, it
appears that the use of fibrin glue can reduce the length of
hospital stay and has no detrimental effect on the complica-
tion rate. 
In conclusion, the present results indicate that fibrin glue
use can decrease the drainage duration and overall drain out-
put after breast lumpectomy and axillary dissection in patients
undergoing level II or III axillary dissection. Thus, fibrin glue
use might be recommended in patients at a risk of high lym-
phatic drainage in order to reduce the length of hospital stays. 
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